Zentopharm GmbH
Quick facts
Phase 2 pipeline
- Fosmidomycin and clindamycin · Infectious Diseases
Fosmidomycin inhibits the enzyme 1-deoxy-D-xylulose-5-phosphate reductoisomerase, which is involved in the biosynthesis of isoprenoids, while clindamycin is a lincosamide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: